Skip to main content
Clinical Trials/NCT03248310
NCT03248310
Recruiting
Not Applicable

A Prospective Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management

Memorial Sloan Kettering Cancer Center3 sites in 1 country600 target enrollmentAugust 9, 2017
ConditionsLymphedema

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lymphedema
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
600
Locations
3
Primary Endpoint
Quality of Life
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

This study is being done to see the long-term results for patients who choose to have surgery for lymphedema (with the vascularized lymph node transfer), compared to patients who choose not to have surgery.

Registry
clinicaltrials.gov
Start Date
August 9, 2017
End Date
August 1, 2026
Last Updated
7 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18-80 years
  • Primary and secondary lymphedema of the upper or lower extremity
  • International Society of Lymphology (ISL) Stage 1, 2, or 3 lymphedema
  • Proficiency in English language

Exclusion Criteria

  • Patients with clotting disorders, venous insufficiency, end-stage lymphedema unless they are on the non-surgical arm.
  • Additionally, if the patient refuses to complete questionnaires, the patient will be excluded from the study and replaced at the discretion of the principal or co-principal investigator.

Outcomes

Primary Outcomes

Quality of Life

Time Frame: up to 40 months

Questionnaire to assess quality of life changes

Study Sites (3)

Loading locations...

Similar Trials